The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•8 April 2026•

1 min read

Nasdaq Approves Listing for Coeptis and Z Squared Merger Under Ticker 'ZSQR'

Key Facts

1Nasdaq has approved the listing of the post-merger company's common stock under the ticker 'ZSQR'.

2The merger involves Coeptis Therapeutics Holdings (COEP) and Z Squared Inc., a digital infrastructure miner.

Coeptis Therapeutics Holdings (COEP) has received approval from Nasdaq to list the common stock of its post-merger entity, Z Squared Inc., under the new ticker symbol 'ZSQR'. This approval marks a critical milestone in the planned merger between the biopharma firm and the digital infrastructure miner. The combined company is set to pivot its strategic focus toward institutional-scale mining of Dogecoin and Litecoin. The transaction is currently expected to close in the second quarter of 2026, pending final regulatory conditions. This move represents a significant transition for Coeptis as it exits the biotechnology sector to enter the cryptocurrency infrastructure space. The Nasdaq listing approval provides a clear regulatory path forward for the new entity's market debut. It underscores the growing trend of public companies diversifying into digital asset mining and infrastructure.